8️⃣ Final Thoughts
Lunex is here to build, not bluff.
No fake hype. No shortcuts. Just real utility and real commitment.
Let’s finish what we started — together.
💙 Thank you, Lunex fam.
Stay tuned.
Faster access to diagnostic information can potentially reduce the threat of antimicrobial resistance and is recommended as one of the CDC's core actions to fight AMR. https://t.co/qphET4loaa
@jtraderco Nice. The only point I see differently is the 50% win rate. Not sure if it is necessary as I guess having a set up with high positive expectancy but with high negative probability can still generate money. Anyway I am not profitable yet!
@jtraderco Thanks for the words... and yes I am with that in mind but I am having problem to understand what to track and when to track... maybe a set up is good but I am tracking bad information... Anyway I minimising much more my losses to continue in this path!